Indian Company Master Data Made Simple
Transgene Biotek Limited.
Transgene Biotek Limited., founded in 1990, carries 35 years of experience in its sector. Its official identification numbers are CIN L85195TG1990PLC011065 and registration 11065. The organization is recorded as company limited by shares under Indian company law. The firm’s authorized share capital totals ₹76.00 crore. Transgene Biotek Limited.’s paid-up capital stands at ₹75.77 crore.
Its primary business activity involves health and social work. It is incorporated within the Hyderabad registry. Its official registered office is situated at Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325. The entity is active and conducting operations. The company’s official contact email is [email protected]. Senior management roles are held by Chowdari Prasad (CFO).
Profile data last updated: 16/12/2024
Company Overview
- CIN
- Date of Incorporation
- 01/03/1990
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2023
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹76,00,00,000.00
- Paid up Capital
- ₹75,77,00,000.00
- Activity
- Health And Social Work
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹12,132.42L | ₹12,047.63L | ₹12,052.25L | ₹12,051.66L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹13,406.17L | ₹13,161.74L | ₹13,098.94L | ₹12,972.30L | ₹0.00L |
| Tangible Book Value | ₹348.47L | ₹416.09L | ₹480.92L | ₹595.94L | ₹0.00L |
| Long Term Debt | ₹610.29L | ₹507.95L | ₹495.04L | ₹476.90L | ₹0.00L |
| Long Term Provisions | ₹11,522.14L | ₹11,522.14L | ₹11,522.14L | ₹11,522.14L | ₹0.00L |
| Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹841.70L | ₹892.15L | ₹816.21L | ₹723.90L | ₹0.00L |
| Total Assets | ₹14,409.16L | ₹14,233.07L | ₹14,235.82L | ₹14,710.04L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹1,737.74L | ₹0.00L |
| Gross PPE | ₹328.50L | ₹1,451.91L | ₹1,451.91L | ₹1,451.75L | ₹0.00L |
| Total Capitalization | ₹1,613.28L | ₹1,579.28L | ₹1,631.92L | ₹2,214.64L | ₹0.00L |
| Common Stock | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹654.52L | ₹655.24L | ₹655.96L | ₹1,141.80L | ₹0.00L |
| Total Debt | ₹1,451.99L | ₹1,400.10L | ₹1,311.25L | ₹1,200.80L | ₹0.00L |
| Other Equity Interest | -₹6,574.01L | ₹122.49L | ₹122.50L | ₹122.50L | ₹0.00L |
| Other Non Current Liabilities | -₹0.01L | ₹17.54L | -₹0.01L | ₹52.62L | ₹0.00L |
| Capital Stock | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹0.00L |
| Total Non Current Assets | ₹14,282.75L | ₹14,122.12L | ₹14,131.35L | ₹14,640.19L | ₹0.00L |
| Invested Capital | ₹2,454.98L | ₹2,471.43L | ₹2,448.13L | ₹2,938.54L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹28.44L | ₹0.77L | ₹0.31L | ₹1.51L | ₹0.00L |
| Net Tangible Assets | ₹348.47L | ₹416.09L | ₹480.92L | ₹595.94L | ₹0.00L |
| Cash And Cash Equivalents | ₹28.43L | ₹0.11L | ₹0.30L | ₹1.51L | ₹0.00L |
| Stockholders Equity | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹1,737.74L | ₹0.00L |
| Other Short Term Investments | ₹0.01L | ₹0.66L | ₹0.01L | ₹0.57L | ₹0.00L |
| Share Issued | ₹757.70L | ₹757.70L | ₹757.70L | ₹757.70L | ₹0.00L |
| Current Assets | ₹126.42L | ₹110.95L | ₹104.47L | ₹69.85L | ₹0.00L |
| Working Capital | -₹1,147.33L | -₹1,003.16L | -₹942.22L | -₹850.79L | ₹0.00L |
| Net Debt | ₹1,423.56L | ₹1,399.99L | ₹1,310.95L | ₹1,199.29L | ₹0.00L |
| Current Debt | ₹841.70L | ₹892.15L | ₹816.21L | ₹723.90L | ₹0.00L |
| Ordinary Shares Number | ₹757.70L | ₹757.70L | ₹757.70L | ₹757.70L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹610.29L | ₹507.95L | ₹495.04L | ₹476.90L | ₹0.00L |
| Current Liabilities | ₹1,273.75L | ₹1,114.11L | ₹1,046.69L | ₹920.64L | ₹0.00L |
| Net PPE | ₹328.50L | ₹167.16L | ₹175.68L | ₹184.68L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | -₹0.01L | -₹0.02L | -₹0.03L | ₹13.97L | ₹0.00L |
| Common Stock Equity | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹1,737.74L | ₹0.00L |
| Other Intangible Assets | ₹654.52L | ₹655.24L | ₹655.96L | ₹1,141.80L | ₹0.00L |
| Other Properties | ₹328.50L | ₹105.34L | ₹105.34L | ₹105.34L | ₹0.00L |
| Inventory | ₹3.40L | ₹3.39L | ₹3.38L | ₹9.46L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹27.66L | ₹0.46L | -₹1.21L | ₹0.09L | ₹0.00L |
| Financing Cash Flow | ₹78.03L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Investing Cash Flow | -₹169.95L | ₹0.00L | -₹1.23L | -₹9.69L | ₹0.00L |
| Free Cash Flow | -₹50.37L | ₹0.46L | -₹0.13L | ₹9.78L | ₹0.00L |
| End Cash Position | ₹28.43L | ₹0.77L | ₹0.31L | ₹1.51L | ₹0.00L |
| Capital Expenditure | -₹169.95L | ₹0.00L | -₹0.15L | ₹0.00L | -₹2.74L |
| Beginning Cash Position | ₹0.77L | ₹0.31L | ₹1.51L | ₹1.42L | ₹0.00L |
| Operating Cash Flow | ₹119.58L | ₹0.46L | ₹0.02L | ₹9.78L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Basic EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| EBITDA | -₹33.99L | -₹43.41L | -₹43.49L | -₹24.86L | ₹0.00L |
| Total Expenses | ₹147.72L | ₹94.38L | ₹543.82L | ₹1,025.96L | ₹0.00L |
| Operating Revenue | ₹26.07L | ₹23.49L | ₹5.51L | ₹8.67L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹24.30L | ₹12.91L | ₹62.36L | ₹22.91L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Reconciled Depreciation | ₹9.32L | ₹9.23L | ₹495.01L | ₹992.44L | ₹0.00L |
| Net Income Continuous Operations | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹0.00L | ₹0.06L | ₹6.63L | -₹4.62L | ₹0.00L |
| Net Income | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Operating Income | -₹121.65L | -₹70.89L | -₹538.31L | -₹1,017.29L | ₹0.00L |
| Diluted Average Shares | ₹751.22L | ₹728.33L | ₹757.70L | ₹757.70L | ₹0.00L |
| Normalized Income | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹24.30L | -₹12.91L | -₹62.36L | -₹22.91L | ₹0.00L |
| EBIT | -₹43.31L | -₹52.64L | -₹538.50L | -₹1,017.29L | ₹0.00L |
| Gross Profit | ₹26.07L | ₹23.43L | -₹1.12L | ₹13.29L | ₹0.00L |
| Cost Of Revenue | ₹0.00L | ₹0.06L | ₹6.63L | -₹4.62L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Net Interest Income | -₹24.30L | -₹12.91L | -₹62.36L | -₹22.91L | ₹0.00L |
| Operating Expense | ₹147.72L | ₹94.32L | ₹537.19L | ₹1,030.58L | ₹0.00L |
| Normalized EBITDA | -₹33.99L | -₹43.41L | -₹43.49L | -₹24.86L | ₹0.00L |
| Net Income Common Stockholders | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Pretax Income | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹26.07L | ₹23.49L | ₹5.51L | ₹8.67L | ₹0.00L |
| Other Operating Expenses | ₹107.62L | ₹53.97L | ₹16.80L | ₹14.46L | ₹0.00L |
| Diluted EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Interest Expense | ₹24.30L | ₹12.91L | ₹62.36L | ₹22.91L | ₹0.00L |
| Basic Average Shares | ₹751.22L | ₹728.33L | ₹757.70L | ₹757.70L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹67.61L | -₹65.55L | -₹600.86L | -₹1,040.20L | ₹0.00L |
| Tax Provision | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 17/04/2015 | Sujana Kadiam | 07167872 | Director | View other directorships |
| 24/05/2019 | Ankita Jain | *****0811Q | Company Secretary | |
| 24/05/2019 | Chowdari Prasad | *****7463Q | CFO | |
| 12/11/2019 | Santhosh Kumar | 08658555 | Director | View other directorships |
| 04/03/2020 | Kollipara Koteswara Rao | 02287235 | Managing Director | View other directorships |
| 03/06/2020 | Swetha Marri | 08754103 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 26/02/2024 | Form MGT-7-26022024_signed | - |
| 28/01/2024 | Form AOC-4(XBRL)-28012024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Ajooni Biotech Limited | L85190PB2010PLC040162 | D-118; Industrial Area; Phase-7; Mohali; Mohali; Punjab; 160059; India |
| Hanman Fit Limited | L85190MH2013PLC240311 | 702 Concord Chs Ltd.,jvpd Scheme Plot No.1 Near Shiv Sagar Hotel,n.s.road Vile Parl, E [w], Mumbai City, Mumbai, Maharashtra, India, 400056 |
| Indoco Remedies Limited | L85190MH1947PLC005913 | Indoco House 166 Cst Roadvidyanagari Marg Kalina Santacruz East, Mumbai, Maharashtra, India, 400098 |
| Kaya Limited | L85190MH2003PLC139763 | 23/c, Mahal Industrial Estate, Mahakali Caves Road Near Paperbox Lane,andheri (east), Mumbai City, Mumbai, Maharashtra, India, 400093 |
| Wyeth Limited | L85190MH1947PLC005963 | Level 6; Platina; Plot No. C-59; G Block; Bandra - Kurla Complex; Bandra (e); Mumbai; Maharashtra; 400098; India |
Address
Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325
FAQ
What is the incorporation date of Transgene Biotek Limited.?
The incorporation date of Transgene Biotek Limited. is 01/03/1990.
Who are the current board members & directors of Transgene Biotek Limited.?
The current board member of Transgene Biotek Limited. are:
- Swetha Marri
- Santhosh Kumar
- Kollipara Koteswara Rao
- Sujana Kadiam
What is the registered address of Transgene Biotek Limited.?
The registered address of Transgene Biotek Limited. is Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325.
What is the Corporate Identification Number of Transgene Biotek Limited.?
The Corporate Identification Number of Transgene Biotek Limited. is L85195TG1990PLC011065.